Elekta Signs Agreement to Acquire CMS

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:

Elekta AB (publ) (STO:EKTAB) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it has signed a purchase agreement to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. Closing of the transaction is expected in

CMS is a worldwide leader in the development, sales and support of advanced radiation therapy planning solutions, supporting over 1,500 sites in clinical operation throughout the world.

“I am very pleased that the process to acquire CMS is proceeding according to plan” commented Tomas Puusepp, President & CEO of Elekta. “The people, products and market position of CMS are highly complementary to Elekta’s corporate structure, technology portfolio and R&D roadmap. Both Elekta’s and CMS customers will benefit from our combined strength in product development and support.”

source: Yahoo Finance